Cinemark Holdings, Inc.
CNK
$31.03
+10.82%
Cinemark Holdings, Inc. is a major operator of movie theaters in the United States and internationally, generating revenue primarily from box office ticket sales, concession stands, and screen advertising. The company is a geographically diverse leader in the motion picture exhibition industry, distinct for its scale and operational footprint across numerous markets. The current investor narrative centers on the stock's significant volatility and perceived undervaluation, as highlighted by recent news of a substantial share buyback program and new institutional investment despite a sharp price decline, reflecting a debate between underlying business resilience and broader sector headwinds facing the theatrical exhibition model.…
CNK
Cinemark Holdings, Inc.
$31.03
Related headlines
CNK 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cinemark Holdings, Inc.'s 12-month outlook, with a consensus price target around $40.34 and implied upside of +30.0% versus the current price.
Average Target
$40.34
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$25 - $40
Analyst target range
A limited group of 6 analysts provide coverage for CNK, indicating it is a mid-cap stock with moderate institutional interest. The consensus sentiment is implied through financial estimates rather than explicit ratings, with an average revenue estimate of $4.03 billion and an average EPS estimate of $3.08 for the coming year, though a specific consensus price target and Buy/Hold/Sell distribution are not provided in the data. The target range can be inferred from earnings estimates, with a low EPS of $2.98 and a high of $3.16, signaling a relatively tight spread of about 6%, which suggests analyst agreement on the fundamental earnings outlook but does not directly translate to a price target range; the lack of explicit price targets may contribute to higher volatility and less efficient price discovery for the stock.
Bulls vs Bears: CNK Investment Factors
The bull and bear cases for CNK are starkly divided, with the bear side currently holding stronger evidence due to the stock's persistent downtrend, severe underperformance, and crippling financial leverage. The bull case hinges entirely on a successful earnings recovery to justify its low forward P/E of 11.22x, supported by management's buyback confidence. The single most important tension in the investment debate is whether the company's operational resilience and projected earnings growth can overcome the severe structural and financial risks facing the theatrical exhibition industry. If the forward EPS of $3.08 is achieved, the stock looks deeply undervalued; if not, the high debt load could become unsustainable.
Bullish
- Strong Forward Earnings Growth: Analysts project a significant earnings recovery, with forward EPS of $3.08, implying a forward P/E of only 11.22x. This low multiple suggests the market is pricing in minimal growth, creating a potential valuation gap if earnings materialize. The company's recent $300 million buyback program further signals management's confidence in this outlook.
- Attractive Valuation on Sales Basis: The stock trades at a Price-to-Sales ratio of 0.86x and an EV/Sales of 1.85x, which appear low for a market leader. This suggests the stock may be undervalued relative to its revenue base, especially if the business stabilizes. The recent 21% price decline has amplified this potential discount.
- Operational Profitability Amid Headwinds: Despite thin gross margins of 18.55%, the company maintains a positive operating margin of 10.97% and a net margin of 4.44%. This demonstrates the core exhibition business can generate profit even in a challenging environment. The return on equity of 34.11%, while leveraged, indicates efficient use of capital.
- Significant Institutional Vote of Confidence: Recent news highlights a new $7 million institutional investment coinciding with a major share buyback authorization. This action during a 21% stock decline suggests sophisticated investors see value not reflected in the current price. It provides a counter-narrative to the prevailing negative sector sentiment.
Bearish
- Extremely High Financial Leverage: The company's debt-to-equity ratio of 9.34 is dangerously high, indicating heavy reliance on debt financing. This leverage amplifies risks during economic downturns or periods of weak box office performance. The current ratio of 0.71 also points to potential short-term liquidity constraints.
- Severe and Persistent Underperformance: The stock has underperformed the SPY by -36.72% over the past year and -16.25% over the past month, indicating deep-seated negative momentum. A 1-year decline of 10.03% and a 6-month decline of 5.31% show the downtrend is entrenched, with the stock trading 20% below its 52-week high.
- Vulnerable Business Model & Sector Headwinds: As a pure-play theater operator, CNK's revenue is tied to the volatile and potentially declining theatrical exhibition model. Recent news on competitor AMC highlights 'deeper structural problems' in the industry, including cash flow declines. The stock's high volatility and -35.06% max drawdown reflect this existential risk.
- Weak Profitability and Thin Margins: Trailing EPS is a minimal $0.05, and gross margins are a razor-thin 18.55%, characteristic of the capital-intensive, low-margin exhibition industry. While forward earnings look better, current profitability is weak, and the business remains highly sensitive to fluctuations in attendance and film slate quality.
CNK Technical Analysis
The prevailing price trend for CNK has been a volatile downtrend over the past year, with the stock down 10.03% on a 1-year basis. As of the latest close of $27.26, the price is trading near the lower end of its 52-week range, approximately 20% above its 52-week low of $21.60 but 20% below its 52-week high of $34.01, positioning it in a zone that could represent a value opportunity if fundamentals stabilize, but also signaling persistent negative momentum. Recent short-term momentum shows a sharp divergence, with a strong 3-month gain of 10.45% being completely erased by a severe 1-month decline of 6.77%, indicating recent selling pressure that has halted the prior recovery attempt and suggests potential trend weakness or a retest of lower support levels. Key technical support is clearly defined at the 52-week low area around $21.60, while resistance sits near the 52-week high of $34.01; a breakdown below $21.60 would signal a new leg down, whereas a sustained move above $34.01 would confirm a major trend reversal. The stock exhibits high volatility, with a 1-month relative strength of -16.25 against the SPY's 9.48% gain, underscoring its significant idiosyncratic risk and underperformance.
Beta
1.04
1.04x market volatility
Max Drawdown
-35.1%
Largest decline past year
52-Week Range
$22-$34
Price range past year
Annual Return
-8.1%
Cumulative gain past year
| Period | CNK Return | S&P 500 |
|---|---|---|
| 1m | +12.3% | +5.3% |
| 3m | +8.2% | +11.5% |
| 6m | +35.6% | +10.9% |
| 1y | -8.1% | +28.7% |
| ytd | +31.9% | +11.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CNK Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided dataset; however, analyst estimates for the full year average $4.03 billion, providing a forward-looking benchmark, but the multi-quarter trend and YoY comparisons cannot be determined from the current data. Profitability metrics show the company is marginally profitable with a trailing EPS of $0.05 and a net margin of 4.44%, but gross margins are notably thin at 18.55%, which is characteristic of the capital-intensive exhibition industry; the operating margin of 10.97% suggests the core business can generate operating profit, though overall profitability remains modest. The balance sheet reveals significant financial risk with an extremely high debt-to-equity ratio of 9.34, indicating heavy reliance on debt financing, while a current ratio of 0.71 points to potential short-term liquidity constraints; the return on equity of 34.11% is elevated, but this is likely amplified by the high financial leverage rather than exceptional operational performance.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CNK Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is 19.44x, while the forward PE is significantly lower at 11.22x, indicating the market expects a substantial improvement in earnings over the next year, which aligns with the analyst consensus EPS estimate of $3.08. Compared to sector averages, the valuation is difficult to contextualize precisely as industry average multiples are not provided in the data; however, the Price-to-Sales ratio of 0.86x and EV/Sales of 1.85x appear low, potentially suggesting a discount if growth prospects materialize. Historical context for the stock's own valuation range is unavailable due to missing historical ratios data, preventing an assessment of whether the current multiples are at the high or low end of its own historical spectrum.
PE
19.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's leveraged balance sheet. With a debt-to-equity ratio of 9.34, CNK is highly vulnerable to interest rate increases or a downturn in cash flow. The current ratio of 0.71 indicates potential difficulty meeting short-term obligations without refinancing. Furthermore, the business model carries inherent operational risk, with thin gross margins of 18.55% leaving little buffer against cost inflation or a weak film slate, making the projected net margin expansion to support $3.08 in EPS a critical but uncertain assumption.
Market & Competitive Risks are pronounced, as the stock trades with high idiosyncratic risk, evidenced by its -16.25 relative strength against the SPY over one month. The entire exhibition sector faces structural threats from streaming and changing consumer habits, a risk highlighted by recent news detailing AMC's 'deeper structural problems.' Valuation compression is a constant threat; while the forward P/E of 11.22x seems low, it could compress further if growth expectations are downgraded, especially given the stock's history of a -35.06% max drawdown.
The Worst-Case Scenario involves a combination of a sustained box office slump, rising interest expenses on its high debt load, and a loss of investor confidence triggering a liquidity crisis. This could force asset sales or highly dilutive equity raises. The realistic downside is significant, with a clear path to retest the 52-week low of $21.60, representing a potential -21% decline from the current price of $27.26. In an extreme bear case mirroring the max drawdown, the stock could fall approximately -35% from recent highs, though the $21.60 level serves as the nearest concrete support and downside target.